TeraFlu® (TeraFlu®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceParacetamol + Phenylephrine + PheniramineParacetamol + Phenylephrine + Pheniramine
Dosage form: & nbsppowder for solution for oral administration [forest berries]
Composition:One packet contains:
Active components: paracetamol 325 mg, phenylramine maleate 20 mg, phenylephrine hydrochloride 10 mg.
Auxiliary components: sucrose 10 000 mg, acesulfame potassium 13 mg, dye red charming E129 (dye FD & C red No. 40) 2,4 mg, the colorant of the brilliant blue E133 (dye FD & C blue No. 1) 0.3 mg, maltodextrin M100 26 mg, silicon dioxide, 13 mg, raspberry natural aroma WONF Durarome (860385 TD0994) 165 mg, cranberry flavoring Durarome - onTural (861149 TD2590) 55 mg, citric acid-725 mg, sodium citrate dihydrate 180 mg, calcium phosphate 35 mg, magnesium stearate 3.2 mg
Description:

Loose powder, consisting of granules of white, yellowish, pinkish and sero-violet. Presence of soft lumps. When content is dissolved sachet in 225 ml of water heated to 75 ± 5 C, an opaque pink-violet color with a touch of odor.

Pharmacotherapeutic group:ARI and "colds" of symptoms remedy (analgesic non-narcotic means + alpha-adrenomimetic + H1-histamine receptor blocker)
ATX: & nbsp

N.02.B.E   Anilides

N.02.B.E.51   Paracetamol in combination with other drugs, excluding psycholeptics

Pharmacodynamics:The combined agent,the effect of which is due to its members components, has antipyretic, analgesic, vasoconstrictive effect, eliminates the symptoms of "colds". Narrows the vessels of the nose, eliminates edema of the nasal mucosa and nasopharynx.
Indications:Symptomatic, therapy of infectious and inflammatory diseases: SARS, including influenza and "cold", accompanied by fever, chills, headache, runny nose, stuffy nose, sneezing and muscle pain.
Contraindications:

Hypersensitivity to individual components of the drug, simultaneous administration of tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, beta-blockers; portal hypertension; alcoholism; deficiency of sugar / isomaltase, intolerance to fructose, glucose-galactose malabsorption, diabetes mellitus, pregnancy, the period of breastfeeding, children under 12 years.

Carefully:With severe atherosclerosis of the coronary arteries, with arterial hypertension, closed-angle glaucoma, severe liver or kidney disease, prostatic hyperplasia, blood diseases, deficiency of glucose-6-phosphate dehydrogenase, congenital hyperbilirubinemia (Gilbert syndrome, Dubin-Johnson and Rotor syndrome), hyperthyroidism, pheochromocytoma, bronchial asthma.
Dosing and Administration:

Inside. The contents of the sachet are dissolved in 1 glass of boiled hot water.

Used in hot condition. You can add sugar to taste. Repeated dose can be taken every 4 hours (no more than 3 doses in 24 hours).

TeraFlu® can be used at any time of the day, but the best effect comes from taking the drug before going to bed, at night. If there is no relief of symptoms during 3 days after the beginning of taking the drug, you need to see a doctor.

Side effects:

Possible: allergic reactions (skin rash, itching, hives, angioedema edema), increased excitability, sleep disturbance, decreased speed of psychomotor reactions, drowsinesscognition, the headangling, tnausea, vomiting, pain in the stomach, palpitations, increased arterial pressure, dry mouth, paresis accomodtions, rise internalneedleznpressureI, the delaybut urine. With prolonged use in large doses hepatotoxic effect, disturbance of the blood picture (anemia, thrombocytopenia, agranulocytosis), nephrotoxicity.

Overdose:

Symptoms (due to paracetamol, manifested after taking more than 10-15 g): pallor of the skin, decreased appetite, nausea, vomiting, pain in the epigastric region, in severe cases - liver failure, hepatonecrosis, increased activity of "liver" transaminases, increased prothrombin time , encephalopathy and coma.

Treatment: gastric lavage in the first 6 hours, the introduction of donators SH-groups and precursors of glutathione-methionine synthesis 8-9 hours after an overdose and acetylcysteine ​​after 12 hours.

Seek medical advice.

Interaction:

Strengthens the effects of MAO inhibitors, sedatives, ethanol.The risk of hepatotoxic effects of paracetamol increases with the simultaneous use of barbiturates, phenytoin, carbamazepine, rifampicin, zidovudine and other inducers of microsomal liver enzymes. Antidepressants, antiparkinsonics, antipsychotics, phenothiazine derivatives - increase the risk of urinary retention, dry mouth, constipation. Glucocorticosteroids increase the risk of increased intraocular pressure.

Paracetamol reduces the effectiveness of uricosuric drugs and improves the effectiveness of indirect anticoagulants. Tricyclic antidepressants enhance the sympathomimetic effect, the simultaneous administration of halothane increases the risk of ventricular arrhythmia. Reduces the hypotensive effect of guanethidine, which, in turn, enhances the alpha-adrenostimulating activity of phenylephrine.

Special instructions:

During the treatment period, it is necessary to refrain from using ethanol (possibly development of hepatotoxic action), vehicle management and occupations drOther potentially hazardousladiesand activitiesti, tIncreased concentration of attention and fastpsychomoto companiesrnk reactions.

Do not get rid of the drug from damaged pouches.

Effect on the ability to drive transp. cf. and fur:During the treatment period, it is necessary to refrain from driving and training drOther potentially hazardousladiesand activitiesti, tIncreased concentration of attention and fastpsychomoto companiesrnk reactions.
Form release / dosage:Powder for solution for oral administration [forest berries]
Packaging:

By 11.5 g of powder in a 6-layer sachet (paper / polyethylene, low density / polyethylene / polyethylene low density / aluminum foil / low density polyethylene).

By 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 or 25 bags in a cardboard bundle, placed individually or in pairs fastened through perforations. Instructions for use are applied to the sachet.

Or 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 or 25 sachets in a cardboard bundle, placed individually or in pairs fastened through perforations, together with instructions for use.

Storage conditions:

At a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

2 years.

The drug should not be used after the expiration date.

Terms of leave from pharmacies:Without recipe
Registration number:LS-001960
Date of registration:11.09.2012
The owner of the registration certificate:Новартис Консьюмер Хелс САНовартис Консьюмер Хелс СА Switzerland
Manufacturer: & nbsp
Representation: & nbspNOVARTIS CONSUMER HELS S.A. (part of Novartis groups) NOVARTIS CONSUMER HELS S.A. (part of Novartis groups) Switzerland
Information update date: & nbsp11.09.2015
Illustrated instructions
    Instructions
    Up
    talkdrugs

    +8 (800)555-35-35

    [email protected]

    The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

    The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

    It is forbidden to copy any instructions of medicinal products, biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

    All rights reserved.© Publishing group "GEOTAR-Media" 2008-2016.